Oruka Therapeutics (ORKA) Total Liabilities (2010 - 2026)

Oruka Therapeutics' Total Liabilities history runs 17 years deep, the most recent figure standing at $17.8 million for Q1 2026.

• On a quarterly basis, Total Liabilities rose 43.38% year-over-year to $17.8 million in Q1 2026; TTM through Mar 2026 was $17.8 million, a 43.38% increase from a year earlier, with the FY2025 full-year figure at $16.7 million, up 20.94% from the prior year.
• Total Liabilities advanced to $17.8 million in Q1 2026 per ORKA's latest filing, from $16.7 million in the prior quarter.
• Across five years, Total Liabilities topped out at $22.5 million in Q3 2025 and bottomed at $841000.0 in Q4 2023.
• The 5-year median for Total Liabilities is $3.1 million (2022), against an average of $7.9 million.
• Across the five-year window, Total Liabilities plunged 63.62% in 2022 and soared 1540.67% in 2024, its largest moves.
• Year by year, Total Liabilities stood at $1.4 million in 2022, then slumped by 40.44% to $841000.0 in 2023, then surged by 1540.67% to $13.8 million in 2024, then increased by 20.94% to $16.7 million in 2025, then advanced by 6.43% to $17.8 million in 2026.
• Per Business Quant, the three latest ORKA Total Liabilities figures stand at $17.8 million (Q1 2026), $16.7 million (Q4 2025), and $22.5 million (Q3 2025).